214 related articles for article (PubMed ID: 6206097)
1. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
[TBL] [Abstract][Full Text] [Related]
3. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
4. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
5. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
6. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
[TBL] [Abstract][Full Text] [Related]
7. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
Lane DA; Preston FE; VanRoss ME; Kakkar VV
Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
9. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
[TBL] [Abstract][Full Text] [Related]
10. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test.
Hafter R; Schröck R; von Hugo R; Graeff H
Scand J Clin Lab Invest Suppl; 1985; 178():137-44. PubMed ID: 3867114
[TBL] [Abstract][Full Text] [Related]
11. An immunoassay for human D dimer using monoclonal antibodies.
Rylatt DB; Blake AS; Cottis LE; Massingham DA; Fletcher WA; Masci PP; Whitaker AN; Elms M; Bunce I; Webber AJ
Thromb Res; 1983 Sep; 31(6):767-78. PubMed ID: 6359576
[TBL] [Abstract][Full Text] [Related]
12. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
Connaghan DG; Francis CW; Lane DA; Marder VJ
Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
Kroneman H; Nieuwenhuizen W; Knot EA
Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
[TBL] [Abstract][Full Text] [Related]
14. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
[TBL] [Abstract][Full Text] [Related]
15. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
[TBL] [Abstract][Full Text] [Related]
16. Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasma.
Gaffney PJ; Edgell T; Creighton-Kempsford LJ; Wheeler S; Tarelli E
Br J Haematol; 1995 May; 90(1):187-94. PubMed ID: 7786784
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the assay for fibrin derivatives using monoclonal antibodies to D-dimer].
Arai M; Kuroso K; Ikematsu S; Fujimaki M; Fukutake K
Rinsho Byori; 1986 Feb; 34(2):157-61. PubMed ID: 3517428
[No Abstract] [Full Text] [Related]
18. Fibrin subunits in venous and arterial thromboembolism.
Gaffney PJ; Brasher M; Lord K; Strachan CJ; Wilkinson AR; Kakkar VV; Scully MF
Cardiovasc Res; 1976 Jul; 10(4):421-6. PubMed ID: 133759
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
Barsotti A; Savarino A
Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
[TBL] [Abstract][Full Text] [Related]
20. [A test for the detection of fibrin in the plasma].
Franke M; Hafter R; von Hugo R; Röbl M; Graeff H
Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):105-9. PubMed ID: 3956964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
